* 3-Dimensional Pharmaceuticals Inc., of Exton, Pa., was awarded atwo-year $750,000 Small Business Innovation Research grant tosupport development of the ThermoFluor assay, a technology forscreening compound libraries for binding to therapeutic agents.
* Antex Biologics, of Gaithersburg, Md., was awarded a Phase IISmall Business Innovation Research grant of $600,000 to advancedevelopment of a vaccine candidate for the sexually transmittedpathogen, Chlamydia trachomatis.
* Cypress Bioscience Inc., of San Diego, said it raised $6.5 million ina private placement and signed a definitive agreement to merge withPRP Inc., a Boston company developing agents to treat blood andplatelet disorders. The private placement consisted of an offering of$4 units comprised of two shares of common stock and one warrant.
(c) 1997 American Health Consultants. All rights reserved.